Officer exercised or converted 12K JNJ derivative securities | OQRO Insider tradesWhy it stands out
Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
All the details
Dates, kept separate
- Transaction date
- Jul 20, 2026
- Reporting period
- Not applicable
- Filed with the SEC
- Jul 21, 2026
OfficerOption exercise
Context
- Classification
option exercise
Code M — exercise or conversion of a derivative security
- Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
- Record ID
- 0000200406-26-000148
Filed / recordedJul 21, 2026, 9:27 PM UTCAdded to OQROOct 2, 2026, 3:52 AM UTC Data qualityVerified: identifiers matched exactly Reporting personVanessa Broadhurst Officer titleEVP, Global Corp Affairs SecurityEmployee Stock Options (Right to Buy) TableDerivative (Table II) Transaction dateJul 20, 2026 Acquired / disposedDisposed (D) Footnotes from the filing
- Awarded under Issuer's Long-Term Incentive Plan. The Stock Option Award vests and is exercisable on the third anniversary of the grant date.
Around the same time
Derivative exercise or conversion — not an open-market buy.
Johnson & Johnson's WWC. Innovative Medicine sold $3.95M of Johnson & Johnson shares. Nobody planned it ahead of time.
Derivative exercise or conversion — not an open-market buy.